Biodyne Co., Ltd. (KOSDAQ:314930)

Market Cap	387.53B -7.6%
Revenue (ttm)	4.98B +9.0%
Net Income	-78.64M
EPS	-2.64
Shares Out	29.76M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,228
Average Volume	98,481
Open	12,400
Previous Close	12,570
Day's Range	12,270 - 12,510
52-Week Range	10,480 - 18,420
Beta	1.41
RSI	52.69
Earnings Date	n/a

About Biodyne

Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1999
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 314930